Article may be outdated

This article is 11 days old. Some details may have changed since publication.

Times of India·3 min read·medium

Stranger Things star's rare disorder charity helps create 37 care guidelines

T
TOI WORLD DESK
Stranger Things star's rare disorder charity helps create 37 care guidelines
✦AI Summary

Actor Gaten Matarazzo and his family's nonprofit, CCD Smiles, have collaborated with medical researchers to publish 37 new clinical guidelines for treating cleidocranial dysplasia. This rare genetic disorder, which affects bone and tooth development, previously lacked standardized care protocols due to its rarity.

Why it matters

Standardized medical guidelines significantly improve the quality of life and treatment outcomes for patients with rare diseases who often face diagnostic delays.

✦Dive DeeperCreate a free account to unlock

When a medical condition affects only a tiny fraction of the population, even experienced doctors may struggle to find enough information to treat it. This has been a longstanding challenge for people with cleidocranial dysplasia (CCD), a rare genetic disorder that affects the development of bones and teeth. Stranger Things actor Gaten Matarazzo, who was born with the condition, has used his public platform to raise awareness and support people facing similar challenges.A new study published online in the Journal of Bone and Mineral Research on January 8, 2026, marks an important development in that effort. Titled Diagnosis, treatment, and management recommendations for cleidocranial dysplasia: A modified Delphi panel, the research establishes 37 expert-consensus recommendations covering diagnosis, treatment and long-term medical care.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscienceentertainment
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in